DJ AstraZeneca PLC ADR Outperforms Market On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
The AstraZeneca PLC ADR $(AZN)$ rose 1.32% to $74.57 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.35% to 21,242.70 and the Dow Jones Industrial Average falling 0.51% to 43,968.64.
The ADR's rise snapped a two-day losing streak.
AstraZeneca PLC ADR closed 14.95% short of its 52-week high of $87.68, which the company reached on August 30th.
The ADR outperformed some of its competitors Thursday, as Eli Lilly & Co. $(LLY)$ fell 14.14% to $640.86, Biogen Inc. $(BIIB)$ fell 1.23% to $127.75, and Johnson & Johnson $(JNJ)$ rose 0.55% to $171.53.
Trading volume (3.4 M) remained 1.2 million below its 50-day average volume of 4.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 7, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
August 07, 2025 17:22 ET (21:22 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。